These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27119523)

  • 1. The effect of atorvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (HMG-CoA), on the prevention of osteoporosis in ovariectomized rabbits.
    Zhou H; Xie Y; Baloch Z; Shi Q; Huo Q; Ma T
    J Bone Miner Metab; 2017 May; 35(3):245-254. PubMed ID: 27119523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin Reduces Circulating Osteoprogenitor Cells and T-Cell RANKL Expression in Osteoporotic Women: Implications for the Bone-Vascular Axis.
    Rattazzi M; Faggin E; Buso R; Di Virgilio R; Puato M; Plebani M; Zaninotto M; Palmosi T; Bertacco E; Fadini GP; Pauletto P
    Cardiovasc Ther; 2016 Feb; 34(1):13-20. PubMed ID: 26506085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro.
    Yuan SY; Sheng T; Liu LQ; Zhang YL; Liu XM; Ma T; Zheng H; Yan Y; Ishimi Y; Wang XX
    Chin J Nat Med; 2016 Apr; 14(4):265-269. PubMed ID: 27114313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
    Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
    Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats.
    Wei J; Wang J; Gong Y; Zeng R
    Mol Med Rep; 2015 Aug; 12(2):1717-26. PubMed ID: 25891179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin, a double weapon in osteoporosis treatment: an experimental and clinical study.
    El-Nabarawi N; El-Wakd M; Salem M
    Drug Des Devel Ther; 2017; 11():1383-1391. PubMed ID: 28496308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isomeric flavonoid aglycones derived from Epimedii Folium exerted different intensities in anti-osteoporosis through OPG/RANKL protein targets.
    Jiang J; Xiao S; Xu X; Ma H; Feng C; Jia X
    Int Immunopharmacol; 2018 Sep; 62():277-286. PubMed ID: 30036771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Carnitine, but not coenzyme Q10, enhances the anti-osteoporotic effect of atorvastatin in ovariectomized rats.
    Murad HA
    J Zhejiang Univ Sci B; 2016 Jan; 17(1):43-53. PubMed ID: 26739525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
    Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
    J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro.
    Li J; Wang GB; Feng X; Zhang J; Fu Q
    Mol Med Rep; 2016 Jan; 13(1):769-77. PubMed ID: 26647856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
    Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
    Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of treadmill exercise on mRNA expression levels of osteoprotegerin, RANKL and RUNX2 in bone tissues of ovariectomized].
    Wang Q; Yang M; Wang J
    Zhongguo Gu Shang; 2013 Nov; 26(11):940-3. PubMed ID: 24605748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro.
    Sato T; Watanabe K; Masuhara M; Hada N; Hakeda Y
    J Bone Miner Metab; 2007; 25(1):19-27. PubMed ID: 17187190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiosteoporotic activity of Davallia formosana.
    Ko YJ; Wu JB; Ho HY; Lin WC
    J Ethnopharmacol; 2012 Jan; 139(2):558-65. PubMed ID: 22155390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tea polysaccharide inhibits RANKL-induced osteoclastogenesis in RAW264.7 cells and ameliorates ovariectomy-induced osteoporosis in rats.
    Xu H; Yin D; Liu T; Chen F; Chen Y; Wang X; Sheng J
    Biomed Pharmacother; 2018 Jun; 102():539-548. PubMed ID: 29587240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based development of an osteoprotegerin-like glycopeptide that blocks RANKL/RANK interactions and reduces ovariectomy-induced bone loss in mice.
    Liu C; Chen X; Zhi X; Weng W; Li Q; Li X; Zou Y; Su J; Hu HG
    Eur J Med Chem; 2018 Feb; 145():661-672. PubMed ID: 29348072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats.
    Lu J; Liu F; Liu D; Du H; Hao J; Yang X; Cui W
    Exp Biol Med (Maywood); 2016 Jun; 241(11):1237-49. PubMed ID: 26908571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway.
    He XF; Zhang L; Zhang CH; Zhao CR; Li H; Zhang LF; Tian GF; Guo MF; Dai Z; Sui FG
    Bosn J Basic Med Sci; 2017 Nov; 17(4):295-301. PubMed ID: 29055350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low‑molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats.
    Jin X; Zhu L; Li X; Jia J; Zhang Y; Sun X; Ma J; Liu Z; Ma X
    Mol Med Rep; 2017 Feb; 15(2):890-898. PubMed ID: 28000877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.